Decoy Therapeutics Inc. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c10e7fd5-080e-476a-bd55-8f67a418bb9e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001615219-23-000030 |
| FY 2021 | $1.8M | 2021-01-01 – 2021-12-31 | evidence 0001615219-22-000028 |
| FY 2020 | $5.2M | 2020-01-01 – 2020-12-31 | evidence 0001615219-21-000026 |
| FY 2019 | $3.5M | 2019-01-01 – 2019-12-31 | evidence 0001615219-20-000014 |
| FY 2018 | $2.0M | 2018-01-01 – 2018-12-31 | evidence 0001615219-20-000014 |
| FY 2017 | $1.3M | 2017-01-01 – 2017-12-31 | evidence 0001615219-19-000008 |
| FY 2016 | $1.0M | 2016-01-01 – 2016-12-31 | evidence 0001615219-19-000008 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001615219-17-000021 |
| FY 2014 | $0 | 2014-02-26 – 2014-12-31 | evidence 0001615219-17-000021 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Decoy Therapeutics Inc. — all facts · Net Income · Operating Income